AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)

10.1016/j.jhep.2009.10.008

Saved in:

Bibliographic Details
Main Authors:	Huynh, H, Ngo, V.C., Soo, K.C., Koong, H.N., Poon, D., Choo, S.P., Toh, H.C., Thng, C.H., Chow, P., Ong, H.S., Chung, A., Goh, B.C., Smith, P.D.
Other Authors:	PHARMACOLOGY
Format:	Article
Published:	2011
Subjects:	Angiogenesis Apoptosis Combined therapy Growth inhibition HCC xenografts
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/27256
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-27256
record_format	dspace
spelling	sg-nus-scholar.10635-272562023-10-26T08:08:55Z AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC) Huynh, H Ngo, V.C. Soo, K.C. Koong, H.N. Poon, D. Choo, S.P. Toh, H.C. Thng, C.H. Chow, P. Ong, H.S. Chung, A. Goh, B.C. Smith, P.D. PHARMACOLOGY Angiogenesis Apoptosis Combined therapy Growth inhibition HCC xenografts 10.1016/j.jhep.2009.10.008 Journal of Hepatology 52 1 79-87 2011-09-29T05:54:20Z 2011-09-29T05:54:20Z 2010 Article Huynh, H, Ngo, V.C., Soo, K.C., Koong, H.N., Poon, D., Choo, S.P., Toh, H.C., Thng, C.H., Chow, P., Ong, H.S., Chung, A., Goh, B.C., Smith, P.D. (2010). AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC). Journal of Hepatology 52 (1) : 79-87. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jhep.2009.10.008 01688278 http://scholarbank.nus.edu.sg/handle/10635/27256 000273509600012 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Angiogenesis Apoptosis Combined therapy Growth inhibition HCC xenografts
spellingShingle	Angiogenesis Apoptosis Combined therapy Growth inhibition HCC xenografts Huynh, H Ngo, V.C. Soo, K.C. Koong, H.N. Poon, D. Choo, S.P. Toh, H.C. Thng, C.H. Chow, P. Ong, H.S. Chung, A. Goh, B.C. Smith, P.D. AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
description	10.1016/j.jhep.2009.10.008
author2	PHARMACOLOGY
author_facet	PHARMACOLOGY Huynh, H Ngo, V.C. Soo, K.C. Koong, H.N. Poon, D. Choo, S.P. Toh, H.C. Thng, C.H. Chow, P. Ong, H.S. Chung, A. Goh, B.C. Smith, P.D.
format	Article
author	Huynh, H Ngo, V.C. Soo, K.C. Koong, H.N. Poon, D. Choo, S.P. Toh, H.C. Thng, C.H. Chow, P. Ong, H.S. Chung, A. Goh, B.C. Smith, P.D.
author_sort	Huynh, H
title	AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
title_short	AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
title_full	AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
title_fullStr	AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
title_full_unstemmed	AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
title_sort	azd6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (hcc)
publishDate	2011
url	http://scholarbank.nus.edu.sg/handle/10635/27256
_version_	1781410589090775040

AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)

Similar Items